Skip to main content


Figure 5 | Child and Adolescent Psychiatry and Mental Health

Figure 5

From: Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?

Figure 5

Mean scores for problems concerning social interactions and tasks occurring in late afternoon (4 pm to 8 pm). Data presented for the overall population (n = 224) and children and adolescent subgroups (intention-to treat, last observation carried forward). At week 12, all improvements from baseline were significant (p ≤ 0.0001).

Back to article page